Avatrombopag
CAS: 570406-98-3
Ref. TM-T7417
| 1mg | 64.00 € | ||
| 2mg | 91.00 € | ||
| 5mg | 119.00 € | ||
| 10mg | 183.00 € | ||
| 25mg | 334.00 € | ||
| 50mg | 554.00 € | ||
| 100mg | 792.00 € | ||
| 500mg | 1,613.00 € | ||
| 1ml*10 (DMSO) | 171.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Product Information
Name:
Avatrombopag
Synonyms:
- YM477, AKR-501, E5501
- 1-(3-Chlor-5-{[4-(4-chlor-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-1,3-thiazol-2-yl]carbamoyl}-2-pyridinyl)-4-piperidincarbons�ure [German]
- 1-(3-Chloro-5-{[4-(4-Chlorothiophen-2-Yl)-5-(4-Cyclohexylpiperazin-1-Yl)Thiazol-2-Yl]Carbamoyl}Pyridin-2-Yl)Piperidine-4-Carboxylic Acid
- 1-(3-Chloro-5-{[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-1,3-thiazol-2-yl]carbamoyl}-2-pyridinyl)-4-piperidinecarboxylic acid
- 1-[3-Chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl]-2-pyridyl]piperidine-4-carboxylic acid
- 1-[3-Chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]-4-piperidinecarboxylic acid
- 4-Piperidinecarboxylic acid, 1-[3-chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]-
- Akr 501
- As 1670542
- Doptelet
- See more synonyms
- E-5501
CAS:
Description:
Avatrombopag (YM477) is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
649.65
Formula:
C29H34Cl2N6O3S2
Purity:
99.41%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T7417 Avatrombopag
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
